Literature DB >> 2116236

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

R I Tepper1, D A Levinson, B Z Stanger, J Campos-Torres, A K Abbas, P Leder.   

Abstract

We have assessed the biologic role of IL-4 by fusing its gene to an immunoglobulin promoter/enhancer and introducing it into transgenic mice. By attenuating the transgene promoter through the insertion of E. coli lac operator sequences, we have created a series of animals that constitutively express varying amounts of IL-4. Overexpression of IL-4 results in a marked increase in serum IgE levels and the appearance of an inflammatory ocular lesion (blepharitis) with characteristic histopathologic features seen in allergic reactions. In addition, expression of the IL-4 transgene in the thymus perturbs T cell maturation, reducing the population of immature CD4+CD8+ thymocytes and peripheral T cells while increasing the population of mature CD8+ thymocytes. These results demonstrate that deregulation of a single cytokine gene in vivo can induce a complex inflammatory reaction resembling that observed in human allergic disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116236     DOI: 10.1016/0092-8674(90)90011-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  101 in total

1.  Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.

Authors:  J E Fischer; J E Johnson; R K Kuli-Zade; T R Johnson; S Aung; R A Parker; B S Graham
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Transgenic regulation in laboratory animals.

Authors:  S Rusconi
Journal:  Experientia       Date:  1991-09-15

3.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Authors:  Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy.

Authors:  N Yano; M Endoh; M Miyazaki; F Yamauchi; Y Nomoto; H Sakai
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 5.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

6.  Molecular cloning of cat interleukin-4.

Authors:  V E Schijns; C M Wierda; E J van Dam; T W Vahlenkamp; M C Horzinek
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase.

Authors:  D J Conrad; H Kuhn; M Mulkins; E Highland; E Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Inducible interleukin-4-secreting cells provoked in mice during chemical sensitization.

Authors:  R J Dearman; L S Ramdin; D A Basketter; I Kimber
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

9.  Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements.

Authors:  D M Ornitz; R W Moreadith; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

10.  IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.

Authors:  Emmanuella Guenova; Yuliya Skabytska; Wolfram Hoetzenecker; Günther Weindl; Karin Sauer; Manuela Tham; Kyu-Won Kim; Ji-Hyeon Park; Ji Hae Seo; Desislava Ignatova; Antonio Cozzio; Mitchell P Levesque; Thomas Volz; Martin Köberle; Susanne Kaesler; Peter Thomas; Reinhard Mailhammer; Kamran Ghoreschi; Knut Schäkel; Boyko Amarov; Martin Eichner; Martin Schaller; Rachael A Clark; Martin Röcken; Tilo Biedermann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.